fda decision tirzepatide Breaking News: Compounding Pharmacies Take the Fight to the Fifth Circuit The Outsourcing Facilities Association (OFA) has filed an appeal challenging the FDA's to restrict compounding pharmacies from producing tirzepatide, the Tirzepatide for Weight Loss |

If your previous pharmacy dispensed 2.5mg/mL and Strive dispenses 5mg/mL at the same milligram dose, your injection volume halves

NOW, LISTEN UP: Seaford Pharmaceuticals journey as a family-owned Canadian company In Season 14 of the NPC Podcast, Seaford Pharmaceuticals President Tamara Seales discusses navigating Canadian pharma regulations, team building, and weaving DEI into the companys fabric

The medication is administered via a once-weekly subcutaneous injection

Just a heads up, people in California may experience increased fulfillment time due to additional compound testing requirements

11,000+ patients worldwide have already trusted us with their lives